Anglikon, September 13, 2021 Vitruvia Medical AG is right on target after the first six months of the year. The Swiss-German company generated revenues of almost 1.3 million euros in the first half of 2021. EBITA (earnings before interest, taxes and amortization) amounted to -1.0 million euros.
The figures reported reflect the fact that only the two subsidiaries LT technologies GmbH, which was consolidated for the first time, and steriPartner GmbH were fully operational during this period. The Circular Clinic Supply Center in Schönebeck—otherwise known as Vitruvia GmbH—started its operative business toward the middle of the year.
Board of Directors confirms full-year forecast
With results for the first half of 2021 in line with expectations, management confirmed its outlook for the full year. The Board of Directors of Vitruvia Medical AG expects group revenues of around five million euros in fiscal 2021, with EBITA at break-even level.
For 2022, when the Circular Clinic Supply Center has been in operation for a full year, revenues are forecast to grow to more than 14 million euros, with an operating profit of almost five million euros.
The six-month report of Vitruvia Medical AG (group) as of June 30, 2021 and the six-month financial statements of Vitruvia Medical AG (group) as of June 30, 2021 are published on the website of Vitruvia Medical AG (www.vitruvia-med.com).